Start Date
February 28, 2011
Primary Completion Date
June 30, 2013
Study Completion Date
August 31, 2013
Farletuzumab
Farletuzumab initial loading dose 5.0 mg/kg intravenous followed by 2.5 mg/kg intravenous for all subsequent doses every 2 weeks for up to 12 months.
Emory University, Atlanta
Lead Sponsor
Morphotek
INDUSTRY